Israel-based ForSight Robotics announced on 18 July it completed a $55m series A financing round to advance clinical trials of its surgical platform Oryom for fully robotic cataract surgery.
The financing round was led by the Adani Group with existing investors Eclipse Ventures and Mithril Capital and